Literature DB >> 15448268

Distance communication transfer of HIV prevention interventions to service providers.

Jeffrey A Kelly1, Anton M Somlai, Eric G Benotsch, Timothy L McAuliffe, Yuri A Amirkhanian, Kevin D Brown, L Yvonne Stevenson, M Isa Fernandez, Cheryl Sitzler, Cheryl Gore-Felton, Steven D Pinkerton, Lance S Weinhardt, Karen M Opgenorth.   

Abstract

Most acquired immunodeficiency syndrome (AIDS) service providers are in countries with little access to scientific developments relevant to their programs. It is critical to transfer advances from the scientific arena to service providers on a global scale. Human immunodeficiency virus (HIV) prevention organizations in 78 countries were randomized to receive either a control condition or a technology transfer condition with an interactive distance learning computer training curriculum and individualized distance consultation. Of 42 nongovernmental organizations in the technology transfer condition, 29 adopted the science-based program in their communities or trained other agencies to also use it. Advanced communication technologies can create a cost-effective infrastructure to disseminate new intervention models to service providers worldwide.

Entities:  

Mesh:

Year:  2004        PMID: 15448268     DOI: 10.1126/science.1100733

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  13 in total

1.  Programmes, resources, and needs of HIV-prevention nongovernmental organizations (NGOs) in Africa, Central/Eastern Europe and Central Asia, Latin America and the Caribbean.

Authors:  J A Kelly; A M Somlai; E G Benotsch; Y A Amirkhanian; M I Fernandez; L Y Stevenson; C A Sitzler; T L McAuliffe; K D Brown; K M Opgenorth
Journal:  AIDS Care       Date:  2006-01

2.  Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations.

Authors:  Jeffrey A Kelly; Freya Spielberg; Timothy L McAuliffe
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

Review 3.  A review of HIV/AIDS system-level interventions.

Authors:  José A Bauermeister; Susan Tross; Anke A Ehrhardt
Journal:  AIDS Behav       Date:  2008-03-28

4.  Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

5.  Core indicators evaluation of effectiveness of HIV-AIDS preventive-control programmes carried out by nongovernmental organizations. A mixed method study.

Authors:  Anna Berenguera; Enriqueta Pujol-Ribera; Concepció Violan; Amparo Romaguera; Rosa Mansilla; Albert Giménez; Carlos Ascaso; Jesús Almeda
Journal:  BMC Health Serv Res       Date:  2011-07-28       Impact factor: 2.655

6.  Effectiveness of an HIV/STD risk-reduction intervention for adolescents when implemented by community-based organizations: a cluster-randomized controlled trial.

Authors:  John B Jemmott; Loretta S Jemmott; Geoffrey T Fong; Knashawn H Morales
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

7.  An exploratory study to examine intentions to adopt an evidence-based HIV linkage-to-care intervention among state health department AIDS directors in the United States.

Authors:  Wynne E Norton
Journal:  Implement Sci       Date:  2012-04-02       Impact factor: 7.327

8.  Defining and assessing evidence for the effectiveness of technical assistance in furthering global health.

Authors:  Gary R West; Sheila P Clapp; E Megan Davidson Averill; Willard Cates
Journal:  Glob Public Health       Date:  2012-05-21

9.  Normative beliefs and sexual risk in China.

Authors:  Li Li; Ying Ying Ding; Zunyou Wu; Mary Jane Rotheram-Borus; Sam Guo
Journal:  AIDS Behav       Date:  2011-08

Review 10.  Communication and marketing as tools to cultivate the public's health: a proposed "people and places" framework.

Authors:  Edward W Maibach; Lorien C Abroms; Mark Marosits
Journal:  BMC Public Health       Date:  2007-05-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.